Li, Hao
Ge, Miao
Pei, Zehua
He, Jinwei
Wang, Congxia
Article History
Received: 28 March 2022
Accepted: 21 December 2022
First Online: 23 December 2022
Declarations
:
: The protocol of the blood-based biomarker sample collection study was approved by the ethical review committee (IRB) of Peking University (IRB 00001052–11014). Written informed consent was obtained from all study participants. All methods were carried out in accordance with relevant guidelines and regulations.
: Not applicable.
: The authors declare that they have no competing interests.